Digoxin for Rate Control in Atrial Fibrillation

Introduction to Digoxin

• The American College of Cardiology recommends digoxin as a rate control agent in atrial fibrillation, as it slows ventricular response by depressing AV nodal conduction, but does not restore or maintain sinus rhythm 1, 2

Mechanism and Clinical Role

• Digoxin controls heart rate through vagotonic effects on the AV node, making it effective for rate control but ineffective for rhythm conversion or maintenance, as stated by the European Heart Journal 3, 4
• The American College of Cardiology suggests digoxin is a second-line rate control agent, recommended after beta-blockers and nondihydropyridine calcium channel blockers (diltiazem, verapamil) 2

Specific Indications for Digoxin

• The American College of Cardiology recommends using digoxin as first-line rate control in patients with atrial fibrillation and heart failure with reduced ejection fraction (HFrEF), where it serves dual purposes of rate control and HF management 1, 5, 6
• Digoxin is recommended for sedentary individuals who do not require exercise rate control, as stated by the American College of Cardiology 1, 2

Critical Limitations of Digoxin

• The European Heart Journal notes that digoxin fails to control heart rate during exercise, which is a major clinical limitation 4, 7
• The American College of Cardiology states that digoxin should NOT be used as sole therapy for paroxysmal atrial fibrillation (Class III recommendation) 1

Common Pitfalls to Avoid

• The American Heart Association, as published in Circulation, advises against using digoxin in pre-excited atrial fibrillation (Wolff-Parkinson-White syndrome), as it can paradoxically increase ventricular response and precipitate ventricular fibrillation 3, 8
• The European Heart Journal warns against relying on digoxin monotherapy for active patients who require exercise rate control, as it will fail during exertion 4, 7